
REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS
Author(s) -
А. В. Павлыш,
А. С. Колбин,
Р. А. Гапешин,
С. М. Малышев
Publication year - 2015
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2015.8.2.003-010
Subject(s) - orphan drug , legislation , rare disease , risk analysis (engineering) , medicine , interpretation (philosophy) , cost effectiveness analysis , intensive care medicine , actuarial science , disease , business , computer science , bioinformatics , cost effectiveness , political science , pathology , law , biology , programming language